V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220008837 | 220003577 | 1.56 | 68 | Palliative (P) | 2013-08-12 | 2013-08-12 | IDARUBICIN | N | N | 220035329 | LI-1 TRIAL |
| 220008838 | 220003578 | 0 | null | Curative (C) | 2013-07-17 | 2013-07-24 | Cisplatin + Docetaxel +Fluorouracil | N | N | 220035332 | IDARUBICIN + MITOXANTRONE + TRETINOIN |
| 220008839 | 220003579 | 1.58 | 53.6 | null | 2017-08-12 | 2017-08-13 | Capecitabine | 02 | null | 220035335 | RUXOLITINIB |
| 220008840 | 220003579 | 1.6 | null | Palliative (P) | null | 2016-12-01 | BENDAMUSTINE + RITUXIMAB | null | null | 220035335 | ERLOTINIB |
| 220008841 | 220003579 | -1 | 92 | Palliative (P) | 2014-05-07 | 2014-05-16 | Methotrexate Intrathecal (any age) | 02 | Y | 220035335 | CTD |
| 220008842 | 220003579 | 1.62 | 111 | Palliative (P) | 2014-09-03 | 2014-09-03 | CYCLOPHOSPHAMIDE + FLUDARABINE | 2 | null | 220035335 | RUXOLITINIB |
| 220008843 | 220003580 | 1.76 | 83 | Palliative (P) | null | 2014-08-26 | DABRAFENIB | N | N | 220035340 | GEFITINIB |
| 220008844 | 220003580 | null | 92.3 | Palliative (P) | 2014-05-12 | 2014-05-23 | Cyclophosphamide TBI Allograft | null | null | 220035340 | CISPLATIN + ETOPOSIDE |
| 220008845 | 220016441 | 1.78 | 12.4 | Curative (C) | 2014-06-27 | 2014-07-02 | Ipilimumab | 2 | N | 220035346 | FLUDARABINE + MELPHALAN |
| 220008846 | 220019021 | 1.52 | 69.2 | Neo-adjuvant (N) | 2013-03-30 | 2013-04-03 | Cisplatin | N | N | 220035347 | CARBO + FLUOROURACIL |
| 220008847 | 220019021 | 1.69 | 92.3 | Palliative (P) | 2015-02-17 | 2015-02-20 | Cisplatin + Docetaxel +Fluorouracil | null | null | 220035347 | CAPECITABINE + CARBOPLATIN |
| 220008848 | 220019021 | null | null | Palliative (P) | null | 2015-10-17 | FLUDARABINE | 2 | null | 220035347 | ECF |
| 220008849 | 220003581 | null | null | Palliative (P) | 2016-01-24 | 2016-02-05 | UKALL XII Induction Phase 1 | null | null | 220035353 | CAPECITABINE + STREPTOZOCIN |
| 220008850 | 220011948 | 1.74 | 85.1 | Palliative (P) | 2013-10-20 | 2013-11-08 | CYTARABINE + MITOXANTRONE | 02 | N | 220035355 | CISPLATIN + ETOPOSIDE |
| 220008851 | 220011948 | 0 | 78.6 | Palliative (P) | 2015-02-05 | 2015-02-13 | Capecitabine | N | N | 220035355 | CAPECITABINE + STREPTOZOCIN |
| 220008852 | 220011948 | 1.67 | 0 | Palliative (P) | 2014-09-20 | 2014-09-20 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | 02 | N | 220035355 | GEFITINIB |
| 220008853 | 220003582 | 1.83 | null | Palliative (P) | 2016-10-06 | 2016-10-07 | Capecitabine | 99 | N | 220035364 | DABRAFENIB + TRAMETINIB |
| 220008854 | 220003582 | 1.61 | 79.6 | Palliative (P) | 2013-07-17 | 2013-07-22 | CISPLATIN + FLUOROURACIL | N | N | 220035364 | DABRAFENIB + TRAMETINIB |
| 220008855 | 220003582 | 1.48 | null | null | 2018-03-08 | 2018-03-09 | Cisplatin + Pemetrexed | N | Y | 220035364 | CAPECITABINE |
| 220008856 | 220003582 | 1.68 | 61 | Palliative (P) | 2016-09-15 | 2016-09-23 | Ipilimumab | 2 | N | 220035364 | DABRAFENIB + TRAMETINIB |
| 220008862 | 220003584 | 1.62 | 0 | Palliative (P) | 2015-10-25 | 2015-10-31 | Cyclophosphamide + Docetaxel | 02 | N | 220035383 | RUXOLITINIB |
| 220008863 | 220011951 | 1.65 | 0 | Palliative (P) | 2015-01-20 | 2015-01-20 | Capecitabine | 01 | N | 220035384 | CARBOPLATIN + PEMETREXED |
| 220008864 | 220011951 | 1.78 | 70 | Palliative (P) | 2015-11-01 | 2015-11-01 | CAPECITABINE + TEMOZOLOMIDE | N | N | 220035384 | ECARBOX |
| 220008865 | 220011951 | 0 | 111 | Palliative (P) | 2017-03-02 | 2017-03-07 | Cytarabine intrathecal | 02 | N | 220035384 | CISPLATIN + FLUOROURACIL |
| 220008866 | 220011951 | 1.49 | 49 | Neo-adjuvant (N) | 2016-07-06 | 2016-07-06 | IDARUBICIN + MITOXANTRONE + Tretinoin | N | N | 220035384 | CYCLOPHOSPHAMIDE |
| 220008867 | 220011951 | null | 102.6 | Palliative (P) | null | 2017-06-22 | FLUOROURACIL + MITOMYCIN + RT | 2 | N | 220035384 | MITOXANTRONE |
| 220008868 | 220011951 | 1.62 | 58 | Palliative (P) | null | 2013-02-17 | INTERFERON | N | N | 220035384 | IRINOTECAN + MDG |
| 220008869 | 220011951 | 1.63 | 66.7 | Palliative (P) | 2015-08-11 | 2015-08-12 | Docetaxel + Trastuzumab (Load) | N | N | 220035384 | CISPLATIN + ETOPOSIDE |
| 220008870 | 220003585 | 1.57 | null | Palliative (P) | 2015-09-26 | 2015-10-01 | VE - Vinorelbine + Epirubicin | Y | N | 220035402 | CAPECITABINE + CISPLATIN |
| 220008871 | 220003585 | 1.7 | 0 | Palliative (P) | 2013-04-19 | 2013-04-24 | DABRAFENIB + TRAMETINIB | N | null | 220035402 | MITOXANTRONE |
| 220008872 | 220003585 | 1.6 | 84.6 | Palliative (P) | 2014-08-27 | 2016-10-31 | Capecitabine (14 days)+Carboplatin | N | N | 220035402 | ROMAZA TRIAL |
| 220008873 | 220003586 | 1.68 | 58 | Curative (C) | 2015-10-27 | 2015-10-27 | CISPLATIN + ETOPOSIDE | 02 | N | 220035412 | DAUNORUBICIN |
| 220008874 | 220003586 | null | 69.3 | Palliative (P) | null | 2013-10-02 | Arsenic trioxide | N | N | 220035412 | TEMOZOLOMIDE |
| 220008875 | 220003586 | 1.61 | 0 | Palliative (P) | 2013-05-03 | 2013-05-04 | RUXOLITINIB | 02 | N | 220035412 | ECARBOX |
| 220008876 | 220003586 | null | null | Palliative (P) | 2014-07-11 | 2014-07-11 | RUXOLITINIB | N | N | 220035412 | LENALIDOMIDE |
| 220008877 | 220003587 | 1.69 | null | null | null | 2015-12-20 | Fludarabine + Melphalan RIC Allo | Y | null | 220035419 | CYTARABINE INTRATHECAL |
| 220008878 | 220003588 | -1 | 85.4 | Palliative (P) | 2015-07-31 | 2015-08-11 | Capecitabine | 02 | N | 220035421 | CAPECITABINE + CISPLATIN |
| 220008879 | 220003588 | 1.67 | 16.3 | Palliative (P) | 2017-06-08 | 2017-11-26 | Cisplatin + Vinorelbine (PO) | N | N | 220035421 | CISPLATIN + FLUOROURACIL |
| 220008880 | 220003588 | 1.54 | 59.8 | Palliative (P) | 2015-04-27 | 2015-04-29 | Capecitabine (14 days)+Carboplatin | N | N | 220035421 | UKALL60+ |
| 220008881 | 220003588 | 1.78 | null | Palliative (P) | 2015-10-05 | 2015-10-16 | Doxorubicin + Ifosfamide | 2 | N | 220035421 | CETUXIMAB + IRINOTECAN + MDG |
| 220008882 | 220003589 | 1.78 | 101.6 | Neo-adjuvant (N) | 2018-02-05 | 2018-02-10 | Cytarabine intrathecal | N | N | 220035428 | CARBO + FLUOROURACIL |
| 220008883 | 220003590 | 1.66 | 67.9 | Palliative (P) | 2014-10-24 | 2014-10-24 | IBRUTINIB | Y | N | 220035432 | OCTREOTIDE |
| 220008884 | 220003590 | null | 14.6 | Palliative (P) | 2015-11-01 | 2015-11-01 | Carboplatin + Liposomal Doxorubicin | N | N | 220035432 | CARBO + FLUOROURACIL |
| 220008885 | 220003590 | 1.65 | 53 | Palliative (P) | 2014-06-17 | 2014-06-17 | ALL UKALL2011 IndB Std Dex (PegAsp) | 2 | N | 220035432 | IPILIMUMAB + NIVOLUMAB |
| 220008889 | 220003592 | null | null | null | 2013-05-31 | 2013-05-31 | DOXORUBICIN | N | N | 220035444 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 220008890 | 220003593 | 1.65 | null | Palliative (P) | 2016-06-01 | 2016-06-08 | ECF | N | null | 220035445 | CISPLATIN + ETOPOSIDE |
| 220008891 | 220003594 | null | null | Palliative (P) | 2013-06-05 | 2013-06-05 | Cisplatin + Etoposide po | Y | N | 220035446 | CAPECITABINE + CARBOPLATIN |
| 220008892 | 220003594 | 1.71 | 66 | Palliative (P) | null | 2013-06-10 | FLUDARABINE | null | null | 220035446 | IMATINIB + HYDROXYCARBAMIDE |
| 220008893 | 220003594 | 1.77 | 67.4 | Palliative (P) | 2017-04-16 | 2017-05-13 | CHOP - 21 days | N | Y | 220035446 | CAPECITABINE |
| 220008894 | 220003595 | null | null | Palliative (P) | 2014-01-08 | 2014-01-24 | FLUOROURACIL | N | N | 220035452 | CTD |